JPMorgan lowered the firm’s price target on Scotts Miracle-Gro (SMG) to $80 from $85 and keeps an Overweight rating on the shares following the earnings report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMG:
- Scotts Miracle-Gro Reports Strong Fiscal 2024 Results
- Scotts Miracle-Gro calls 2025 EBITDA guidance ‘conservative’
- Scotts Miracle-Gro sees 2025 EBITDA of $570M-$590M
- Scotts Miracle-Gro reports Q4 adjusted EPS ($2.31), consensus ($1.97)
- Scotts Miracle-Gro to outline FY25 expectations during conference call